About

Provided by Baker McKenzie

Our Life Sciences group in Paris, led by Julie Yeni, comprises a dedicated group of lawyers: subject-matter experts in healthcare and life sciences regulatory, commercial and compliance work, as well as a wider group of practitioners from various practice areas, in particular, corporate/M&A, digital health/data, IP and product liability, with strong expertise and significant proportion of client portfolio in life sciences sector. This enables us to provide our clients with strong understanding of their business, strong industry knowledge and full-service offering.

Chambers Review

Provided by Chambers

Pharma/Life Sciences - France

4
Band 4

What the Team is Known For

Baker McKenzie assists pharmaceutical companies with regulatory and corporate issues, including acquisitions and post-acquisition matters. The law firm also provides advice on compliance, market access and unfair competition cases. The team is well versed in cross-border matters.

Strengths

Provided by Chambers

Notable Practitioners

Provided by Chambers

3
Julie Yeni
3
Band 3

Julie Yeni acts on a broad range of regulatory mandates, including post-M&A integration issues and market access matters.

She is smart, witty and trustworthy. Her advice is always sharp and on point.

She is a good expert. She is very reactive and gives good, structured advice.

Julie is a trusted lawyer who I have the pleasure to collaborate with. She has a very good knowledge of the pharma sector, and she is solution-oriented and very pragmatic in her approach.

Julie is always available. She has the best interests of her clients at heart. 

She is attentive to our needs and offers adapted responses.

Ranked Lawyers at
Baker McKenzie

Provided by Chambers
Filter by
Band

France

Pharma/Life Sciences: Regulatory

3
Julie Yeni
3
Band 3

Members

Provided by Baker McKenzie

Julie Yeni

Head of Department

Clients

Provided by Baker McKenzie

AbbVie

BMS - Bristol-Myers Squibb

Johnson & Johnson

Laboratoires Servier

Industries

Provided by Baker McKenzie

medical devices companies

pharmaceuticals